Third Harmonic Non Current Assets Total Over Time
| THRD Stock | USD 10.84 0.04 0.37% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Third Harmonic Performance and Third Harmonic Correlation. Third |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Third Harmonic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Third Harmonic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Assets Total Analysis
Compare Third Harmonic Bio and related stocks such as Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Non Current Assets Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FATE | 1.2 M | 1.2 M | 1.3 M | 932 K | 1.3 M | 2.3 M | 1.7 M | 2.7 M | 7.8 M | 75.2 M | 128.1 M | 288 M | 203.5 M | 174.7 M | 183.4 M |
| SANA | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 271.4 M | 345.8 M | 571.3 M | 378.3 M | 351.8 M | 352.1 M |
| CRBU | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 11.7 M | 51.2 M | 113.5 M | 93.4 M | 60.4 M |
| RCUS | 10 M | 10 M | 10 M | 10 M | 10 M | 10 M | 10 M | 13.6 M | 16 M | 10.4 M | 37.2 M | 910.6 M | 278 M | 264 M | 211.7 M |
| KPTI | 358 K | 358 K | 357 K | 270 K | 12.6 M | 37.8 M | 48.7 M | 31.9 M | 6.6 M | 21.3 M | 23.5 M | 47.2 M | 31.4 M | 6.5 M | 6.2 M |
| XFOR | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.9 M | 421 K | 924 K | 31.4 M | 39.6 M | 29.3 M | 26.9 M | 25.2 M | 19.2 M |
| HOOK | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 5.9 M | 15.7 M | 16.3 M | 23.9 M | 23.3 M | 14.2 M | 16.2 M |
Third Harmonic Bio and related stocks such as Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Non Current Assets Total description
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Third Harmonic Bio | THRD |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 10.84
Check out Third Harmonic Performance and Third Harmonic Correlation. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Third Harmonic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.